Navin Fluorine International Limited was incorporated in June 25th 1998. The Company belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated fluorochemicals complex in India since 1967. The company primarily focuses on fluorine chemistry - producing refrigeration gases chemicals inorganic bulk fluorides specialty organofluorines and offers Contract Research and Manufacturing Services at Surat Gujarat and Dewas Madhya Pradesh.Navin initiated the CDM project to reduce green house gas HCFC 23 in June 2006 with Ineos Fluor as technology partners and received UNFCCC approval in March 2007. Navin Fluorine has developed more than 40 products on commercial scale using indigenously built multipurpose plants.The company has ability to produce some of the niche organofluorine molecules. It offers a diversified portfolio of advanced fluorine derivatives to the world with wide ranging applications in pharma agro and petrochemicals. Navin Fluorine has an impressive clientele consisting of several fortune 500 companies which include five of the top ten global crop protection companies and three of the top ten global chemical companies.A positive mind set holistic approach and thorough professionalism forms the core of the team named Navin Fluorine. Quality is what we aspire for in every endeavor of ours. Navin Fluorine's strict vigil on the environmental norms and safety measures at every step of the manufacturing process has resulted in elevating Navin as an entity to rely upon without inhibition.During FY2016 the Company entered into a Joint Venture (JV) Agreement with Piramal Enterprises Limited (PEL) and accordingly a Company by the name of Convergence Chemicals Private Limited (CCPL) has been formed to leverage the Company's rich legacy in fluorine chemistry and the deep outreach of the JV partner in the healthcare space. PEL holds 51% and the Company owns 49% of the equity share capital of CCPL. During the year 2016 the Company entered into an agreement with Honeywell to work together on the new generation refrigerant gas HFO 1234yf. HFO-1234yf is a next-generation hydro fluoro-olefin (HFO) refrigerant with GWP less than 1 and is a near drop-in replacement for R-134a a hydro fluoro carbon (HFC) for use in vehicle air conditioning systems globally. This agreement depicts Honeywell's confidence in Company's capabilities in developing new generation fluoro intermediates.At the 19th Annual General Meeting of the Company held on 29 June 2017 Members had passed Resolution approving sub-division of shares in the ratio of 5 Equity Shares of Rs2 each for every 1 Equity Share of Rs10 each. The record date for the aforesaid sub-division was 20 July 2017. Accordingly the face value of equity shares of the Company stands reduced to Rs2/- per share.During the current year the Company approved a capital expenditure of Rs11500 lakhs towards creating additional cGMP capacity and associated infrastructure. This capex is underway at the Company's Dewas facility which is the hub of the CRAMS activities. During the year 2018 Company's business relating to manufacture and sale of Specialty Fluorochemicals at Dahej was transferred to Convergence Chemicals Private Limited with effect from 1 December 2017 on a going concern basis by way of slump sales together with all the identified assets liabilities consents permissions services of employees etc.During FY 2019 the Company had entered into a Joint Venture (JV) agreement with Piramal Enterprises Limited (PEL) and accordingly a company by the name of Convergence Chemicals Private Limited (CCPL) has been formed to leverage the Company's capability in niche fluorination chemistry and deep outreach of the JV partner in the healthcare space. PEL holds 51% and the Company owns 49% of the equity share capital of CCPL. During the year 2019 a 100% subsidiary NFIL (UK) Ltd was formed in the UK to acquire the balance shareholding of 49% from the shareholders of Manchester Organics Ltd. During the year the Company made further infusion of 830 K into NFIL (UK) Ltd. which has been utilized to service the HDFC Bahrain Term Loan taken by NFIL (UK) Ltd. to part finance the 49% acquisition of MOL.During FY 2019 the Company made investment in 830000 equity shares of 1/- each of NFIL (UK) Ltd. and 1372537 equity shares of RMB 1/- each of Navin Fluorine (Shanghai) Co. Ltd. The Company also made investments in schemes of various mutual funds aggregating to Rs 27128.71 lakhs and during this period realized Rs 25548.06 lakhs on redemption of units of various mutual funds and debentures.